Holen Sie sich die Stockscreener-App
48.82
1.84%
-0.97
Schlusskurs vom Vortag:
$49.79
Offen:
$49.53
24-Stunden-Volumen:
72,565
Relative Volume:
0.13
Marktkapitalisierung:
$2.31B
Einnahmen:
$1.10B
Nettoeinkommen (Verlust:
$186.50M
KGV:
12.91
EPS:
3.7817
Netto-Cashflow:
$267.19M
1W Leistung:
-7.49%
1M Leistung:
-10.89%
6M Leistung:
-26.17%
1J Leistung:
-25.96%
1-Tages-Spanne:
$48.74
$49.87
1-Wochen-Bereich:
$48.82
$53.83
52-Wochen-Spanne:
$42.62
$71.07
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
48.80 | 2.36B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
18.25 | 58.50B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.81 | 42.84B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.19 | 40.68B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
73.58 | 30.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.10 | 21.36B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Hochstufung | Sidoti | Neutral → Buy |
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference - The Manila Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Assessing a Promising 29.74% Potential Upside - DirectorsTalk Interviews
Is This the Right Time to Add PBH Stock to Your Portfolio? - Yahoo Finance
Precision Trading with Prestige Consumer Healthcare Inc. (PBH) Risk Zones - Stock Traders Daily
Prestige Consumer Healthcare stock holds steady as investors watch valuation and growth - AD HOC NEWS
Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test - Financial Times
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Exploring A 29% Upside Potential - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH) Investor Outlook: Exploring a 32% Upside Potential - DirectorsTalk Interviews
Nearly 40,000 Bottles of Eye Drops Recalled Nationwide - Yahoo
Nearly 40,000 eye drop bottles are recalled over potential contamination - The Seattle Times
40,000 bottles of eye drops across the US recalled over issues with sterility of product - inkl
Clear Eyes Maximum Itchy Eye Relief Recall: FDA Announces 39,060 Bottles RecalledNews and Statistics - IndexBox
Nearly 40,000 eye drops recalled nationwide over possible contamination - Fox Business
Great Lakes Advisors LLC Takes $2.98 Million Position in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination - Fox Business
Clear Eyes eye drops recalled over sterility concerns - qz.com
FDA announces nationwide recall of nearly 40,000 Clear Eyes eye-drop bottles over potential contamination - The Economic Times
Is Prestige Consumer Healthcare’s (PBH) Upgraded 2027 Outlook and Halted Buybacks Reframing Its Growth Story? - webull.com
Rice Hall James & Associates LLC Acquires Shares of 689,692 Prestige Consumer Healthcare Inc. $PBH - MarketBeat
FDA recalls over 39K bottles of CLEAR EYES Maximum Itchy Relief drops - Glance by Eyes On Eyecare
Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript - AOL.com
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 31.96% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare (PBH) Holds Near $51.38 as Range-Bound Trading PersistsVolume Dry Up - vinanet.vn
ETFs Investing in Prestige Consumer Healthcare Inc Stocks - TradingView
Prestige Consumer Healthcare Announces Operations Leadership Transition - The Globe and Mail
Prestige Consumer Healthcare's Jeffrey Zerillo to Retire as SVP, Operations - TradingView
Prestige Consumer Healthcare Inc. Announces Retirement of Jeffrey Zerillo from Senior Vice President, Operations, Effective August 14, 2026 - marketscreener.com
Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover? - Yahoo Finance
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare at Canaccord Genuity: growth bets build - Investing.com
Prestige Consumer Healthcare (NYSE:PBH) Upgraded by Zacks Research to "Hold" Rating - MarketBeat
Understanding Momentum Shifts in (PBH) - Stock Traders Daily
PBH: Deals Increase Sales Base by More than 20% - Smartkarma
Renaissance Technologies LLC Has $2.17 Million Stake in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Quantinno Capital Management LP Acquires 19,281 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth Conference - The Manila Times
Prestige Consumer Executives Set for Aug. 12 Fireside Chat - Stock Titan
Prestige Consumer Healthcare In (PBH) Stock Forecasts - Yahoo! Finance Canada
Prestige Consumer Healthcare (PBH): Analyst Ratings and Growth Potential Offer 23% Upside for Investors - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein - The National Law Review
Prestige Consumer Healthcare In (PBH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Prestige Consumer Healthcare Q1 Earnings Call Highlights - TradingView
Prestige Consumer Healthcare (NYSE:PBH) Issues Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Prestige Consumer Healthcare (PBH) Stock Faces Margin Questions Despite Record Cash Flow - webull.com
Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions - Yahoo Finance
Prestige Consumer Healthcare Inc. $PBH Shares Bought by First Trust Advisors LP - MarketBeat
CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72 - Moomoo
Prestige Consumer Healthcare Inc (PBH) Stock News Today - TradingKey
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised - cnhinews.com
Prestige Consumer Healthcare Stock (PBH) Opinions on Recent Earnings and M&A Activity - Quiver Quantitative
Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH) - The Globe and Mail
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.22%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):